Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$30.46 - $46.04 $368,566 - $557,084
12,100 Added 45.66%
38,600 $1.18 Million
Q2 2023

Aug 11, 2023

BUY
$31.57 - $37.73 $836,605 - $999,844
26,500 New
26,500 $989,000
Q1 2022

May 13, 2022

SELL
$34.38 - $65.77 $127,206 - $243,348
-3,700 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$63.78 - $97.86 $3.72 Million - $5.71 Million
-58,300 Reduced 94.03%
3,700 $261,000
Q1 2021

May 13, 2021

SELL
$23.17 - $38.3 $653,394 - $1.08 Million
-28,200 Reduced 31.26%
62,000 $2.24 Million
Q4 2020

Feb 12, 2021

BUY
$18.28 - $23.85 $146,240 - $190,800
8,000 Added 9.73%
90,200 $2.14 Million
Q3 2020

Nov 13, 2020

BUY
$12.91 - $18.51 $1.06 Million - $1.52 Million
82,200 New
82,200 $1.49 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.